November 5, 2019

Newton, Massachusetts, (Nov. 05, 2019) 

AcuityBio Corporation, a developer of novel drug-delivery combination products, announced that it has received a notice of allowance from the United States Patent and Trademark Office for Application 20170172720 . “

“We are extremely pleased to have received this patent allowance. This allowance further validates the...

Please reload

Copyright © AcuityBio Corporation 2018. All rights reserved.

Primary Contact: 

Created by Brodly Inc.